Metabolomic alteration induced by psychotropic drugs: short-term metabolite profile as a predictor of weight gain evolution - Université de Lille Accéder directement au contenu
Article Dans Une Revue Clinical and translational science Année : 2021

Metabolomic alteration induced by psychotropic drugs: short-term metabolite profile as a predictor of weight gain evolution

Résumé

Psychotropic drugs can induce strong metabolic adverse effects, potentially increasing morbidity and/or mortality of patients. Metabolomic profiling, by studying the levels of numerous metabolic intermediates and products in the blood, allows a more detailed examination of metabolism dysfunctions. We aimed to identify blood metabolomic markers associated with weight gain in psychiatric patients. Sixty-two patients starting a treatment known to induce weight gain were recruited. Two hundred and six selected metabolites implicated in various pathways were analyzed in plasma, at baseline and after 1 month of treatment. Additionally, 15 metabolites of the kynurenine pathway were quantified. This latter analysis was repeated in a confirmatory cohort of 24 patients. Among the 206 metabolites, a plasma metabolomic fingerprint after 1 month of treatment embedded 19 compounds from different chemical classes (amino acids, acylcarnitines, carboxylic acids, catecholamines, nucleosides, pyridine, and tetrapyrrole) potentially involved in metabolic disruption and inflammation processes. The predictive potential of such early metabolite changes on 3 months of weight evolution was then explored using a linear mixed-effects model. Of these 19 metabolites, short-term modifications of kynurenine, hexanoylcarnitine, and biliverdin, as well as kynurenine/tryptophan ratio at 1 month, were associated with 3 months weight evolution. Alterations of the kynurenine pathway were confirmed by quantification, in both exploratory and confirmatory cohorts. Our metabolomic study suggests a specific metabolic dysregulation after 1 month of treatment with psychotropic drugs known to induce weight gain. The identified metabolomic signature could contribute in the future to the prediction of weight gain in patients treated with psychotropic drugs.
Fichier principal
Vignette du fichier
Lenski et al..pdf (456.09 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03677308 , version 1 (24-05-2022)

Licence

Identifiants

Citer

Chin B. Eap, Aurelien Thomas, Delphine Allorge, Philippe Conus, Armin von Gunten, et al.. Metabolomic alteration induced by psychotropic drugs: short-term metabolite profile as a predictor of weight gain evolution. Clinical and translational science, 2021, Clinical and translational science, pp.2544-2555. ⟨10.1111/cts.13122⟩. ⟨hal-03677308⟩

Collections

UNIV-LILLE
4 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More